New SpO2 sensor put to the test in kids
NCT ID NCT07615738
First seen Jun 01, 2026 · Last updated Jun 23, 2026 · Updated 6 times
Summary
This study will check how well a new pulse oximeter sensor works in hospitalized infants and children aged 28 days to 12 years. Researchers will compare the sensor's oxygen readings to those from a standard blood test. The goal is to see if the device is accurate, comfortable, and easy to use across different skin tones.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPO2 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Nebraska Medical Center Children's Hospital
Omaha, Nebraska, 68114, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
SpO2 sensor (device)
What this could lead to
If successful, this could lead to a more reliable and user-friendly pulse oximeter for monitoring oxygen levels in young patients.
What could go wrong
This is an early-stage device validation study, not a treatment trial. The sensor may not perform equally across all skin tones or patient conditions.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.